Stock AHCO ADAPTHEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AdaptHealth Corp.

Equities

AHCO

US00653Q1022

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
9.85 USD -2.76% Intraday chart for AdaptHealth Corp. +0.41% +35.12%
Apr. 17 AdaptHealth Names Suzanne Foster as CEO MT
Apr. 17 AdaptHealth Names Suzanne Foster CEO DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 442.5 2,681 3,234 2,590 984.1 1,319 - -
Enterprise Value (EV) 1 782.2 3,366 5,303 4,732 3,055 3,302 3,300 3,277
P/E ratio -16.6 x -30.5 x 36.5 x 58.2 x -1.44 x 12.7 x 10.1 x 7.77 x
Yield - - - - - - - -
Capitalization / Revenue 0.84 x 2.54 x 1.32 x 0.87 x 0.31 x 0.4 x 0.37 x 0.35 x
EV / Revenue 1.48 x 3.19 x 2.16 x 1.59 x 0.95 x 1 x 0.94 x 0.86 x
EV / EBITDA 6.36 x 16.4 x 9.37 x 7.97 x 4.55 x 4.84 x 4.51 x 4.15 x
EV / FCF 20 x 21.6 x 52.8 x -270 x 21.3 x 20.6 x 17.9 x 14.3 x
FCF Yield 5% 4.63% 1.89% -0.37% 4.69% 4.86% 5.6% 7.01%
Price to Book -11.8 x 9.79 x 1.59 x 1.19 x 0.67 x 0.88 x 0.8 x 0.73 x
Nbr of stocks (in thousands) 40,296 71,391 132,215 134,732 134,991 133,933 - -
Reference price 2 10.98 37.56 24.46 19.22 7.290 9.850 9.850 9.850
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 529.6 1,056 2,455 2,971 3,200 3,317 3,519 3,810
EBITDA 1 123 205.6 565.9 593.8 670.8 682 731.4 789.4
EBIT 1 60.45 123.2 307.9 242.6 288 284.4 324.8 396.2
Operating Margin 11.41% 11.66% 12.54% 8.17% 9% 8.57% 9.23% 10.4%
Earnings before Tax (EBT) 1 -11.73 -70.67 191 97.9 -723.8 144.3 169 -
Net income 1 -15 -64.48 156.2 69.32 -678.9 104.3 130.9 163.7
Net margin -2.83% -6.1% 6.36% 2.33% -21.21% 3.14% 3.72% 4.3%
EPS 2 -0.6600 -1.230 0.6700 0.3300 -5.060 0.7759 0.9725 1.268
Free Cash Flow 1 39.09 155.9 100.4 -17.56 143.2 160.4 184.9 229.9
FCF margin 7.38% 14.76% 4.09% -0.59% 4.47% 4.84% 5.25% 6.03%
FCF Conversion (EBITDA) 31.77% 75.81% 17.74% - 21.35% 23.52% 25.27% 29.12%
FCF Conversion (Net income) - - 64.3% - - 153.81% 141.17% 140.43%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 653.3 702.1 706.2 727.6 756.5 780.3 744.6 793.3 804 858.2 769.9 821.1 839 886.7 819.4
EBITDA 1 156.3 158.1 137.6 150 160.2 146 134 171 161.2 204.6 139.1 170.5 172.4 199.9 155.5
EBIT 1 86.45 80.85 60.61 70.53 67.83 43.61 40.15 71.75 63.86 112.3 42.57 69.76 71.55 100.5 59.36
Operating Margin 13.23% 11.52% 8.58% 9.69% 8.97% 5.59% 5.39% 9.04% 7.94% 13.08% 5.53% 8.5% 8.53% 11.34% 7.24%
Earnings before Tax (EBT) 1 70.41 33.5 47.83 24.1 22.81 3.162 14.96 20.44 -487.5 -271.7 7.841 24.92 34.44 60.46 -
Net income 1 58.09 22.94 41.75 14.03 16.12 -2.588 15.71 13.98 -454.1 -254.5 5.347 24.82 25.02 49.12 16.09
Net margin 8.89% 3.27% 5.91% 1.93% 2.13% -0.33% 2.11% 1.76% -56.47% -29.65% 0.69% 3.02% 2.98% 5.54% 1.96%
EPS 2 0.2000 0.1500 0.0800 0.0900 0.1100 -0.0200 0.1155 0.0900 -3.370 -1.910 0.0488 0.1812 0.1729 0.3750 0.1146
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/10/22 8/9/22 11/8/22 2/27/23 5/9/23 8/8/23 11/7/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 340 685 2,069 2,142 2,071 1,983 1,981 1,958
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.761 x 3.33 x 3.657 x 3.607 x 3.087 x 2.907 x 2.709 x 2.48 x
Free Cash Flow 1 39.1 156 100 -17.6 143 160 185 230
ROE (net income / shareholders' equity) 41.9% 34.9% 14.4% 4.54% 7.89% 7.82% 9.95% 11.4%
ROA (Net income/ Total Assets) -3.27% 5.24% 4.42% 1.83% 1.49% 2.78% 3.8% 4.78%
Assets 1 458 -1,231 3,532 3,793 -45,490 3,746 3,449 3,426
Book Value Per Share 2 -0.9300 3.840 15.40 16.10 10.90 11.20 12.20 13.60
Cash Flow per Share 2 2.680 3.730 2.280 2.690 3.580 3.630 4.010 4.150
Capex 1 21.3 39.8 203 391 337 337 346 344
Capex / Sales 4.03% 3.76% 8.28% 13.18% 10.55% 10.17% 9.82% 9.04%
Announcement Date 2/25/20 3/4/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for AdaptHealth Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
9.85 USD
Average target price
11.85 USD
Spread / Average Target
+20.30%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ADAPTHEALTH CORP. Stock AdaptHealth Corp.
+35.12% 1.32B
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.72% 184B
MEDTRONIC PLC Stock Medtronic plc
-2.60% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.79% 67.78B
DEXCOM, INC. Stock DexCom, Inc.
+2.66% 50.66B
CENCORA, INC. Stock Cencora, Inc.
+16.39% 47.64B
HOYA CORPORATION Stock Hoya Corporation
+4.60% 41.12B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.38% 26.3B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.52% 26.04B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.17% 24.71B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AHCO Stock
  4. Financials AdaptHealth Corp.